Dr. Faiaz Mahmud Rasul , MD
Internal Medicine • Cocoa, FL
990 Palm St Ste 1
Cocoa, FL 329275100
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 15, 2006; this date does not establish years in practice.
-
Published CMS data list 1,156 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 570 service units.
- 99215 — Established patient outpatient office visit: 227 service units.
- 99213 — Established patient outpatient office visit: 88 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 12,075 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Alprazolam — 561 prescription fills, including refills.
- Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) — 429 prescription fills, including refills.
- Rosuvastatin Calcium — 364 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 192 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: 687. Middle half: 277 to 1,489.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,918 in 2020 to 1,156 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
990 Palm St Ste 1
Cocoa, FL 329275100
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1990
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
201 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $144,337 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $102,170 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
21,564 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,355,997 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,601.49 across 74 records.
By nature of payment
- Food and Beverage: $1,601.49 across 74 records.
Reporting-company totals (3 largest of 24)
- ABBVIE INC.: $227.94 across 14 records.
- ABIOMED: $164.28 across 4 records.
- Novo Nordisk Inc: $143.69 across 8 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
36 years (graduated 1990)
CMS Doctors and Clinicians data list 1990 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Rasul has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Rasul as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Cocoa and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: 687. Middle half: 277 to 1,489.
Too few clinicians listed under Internal Medicine in Cocoa have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: $68,256. Middle half: $27,620 to $138,398.
Too few clinicians listed under Internal Medicine in Cocoa have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: $52,728. Middle half: $20,807 to $107,475.
Too few clinicians listed under Internal Medicine in Cocoa have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: 1,318. Middle half: 158 to 5,882.
Too few clinicians listed under Internal Medicine in Cocoa have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: $86,865. Middle half: $8,159 to $434,445.
Too few clinicians listed under Internal Medicine in Cocoa have Medicare Part D data for 2024 to compare.
8 active clinicians are listed under Internal Medicine with a practice address in Cocoa, FL (10,165 in Florida).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 40% from 1,918 in 2020 to 1,156 in 2024.
- 2020: 1,918
- 2021: 1,550
- 2022: 1,259
- 2023: 1,253
- 2024: 1,156
-
Medicare-allowed amount
Medicare-allowed amount decreased 32% from $211,431 in 2020 to $144,337 in 2024.
- 2020: $211,431
- 2021: $194,737
- 2022: $158,269
- 2023: $163,135
- 2024: $144,337
-
Paid by Medicare
Paid by Medicare decreased 33% from $153,155 in 2020 to $102,170 in 2024.
- 2020: $153,155
- 2021: $141,809
- 2022: $114,045
- 2023: $117,742
- 2024: $102,170
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 27% from 16,573 in 2020 to 12,075 in 2024.
- 2020: 16,573
- 2021: 15,212
- 2022: 13,769
- 2023: 12,398
- 2024: 12,075
-
30-day fills
30-day fills decreased 18% from 26,321 in 2020 to 21,564 in 2024.
- 2020: 26,321
- 2021: 24,892
- 2022: 23,094
- 2023: 21,287
- 2024: 21,564
-
Part D drug cost
Part D drug cost stayed about the same: $1,455,361 in 2020 and $1,355,997 in 2024.
- 2020: $1,455,361
- 2021: $1,406,117
- 2022: $1,426,339
- 2023: $1,467,016
- 2024: $1,355,997
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 58% from $3,821.63 in 2021 to $1,601.49 in 2025.
- 2021: $3,821.63
- 2022: $1,995.88
- 2023: $2,189.32
- 2024: $1,655.24
- 2025: $1,601.49
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 74 records totaling $1,601.49.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABIOMED |
Food and Beverage
In-kind items and services
|
— | General | $125.22 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $115.93 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $33.51 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $33.22 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.87 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.87 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $28.44 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $28.15 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $28.03 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
CAMZYOS | General | $27.53 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $25.28 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $23.92 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $23.92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $23.90 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $22.96 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $22.85 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $22.43 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $22.33 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $22.25 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $21.93 |
| Azurity Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EDARBI | General | $21.61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $21.11 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $21.07 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $21.05 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $21.03 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
570 | 144 | $248.88 | $119.39 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
227 | 117 | $300.00 | $168.13 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
88 | 60 | $152.00 | $88.36 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
79 | 79 | $312.03 | $125.32 |
|
93306
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
|
59 | 56 | $344.00 | $183.13 |
|
96372
Injection of drug or substance under skin or into muscle
|
47 | 15 | $45.00 | $12.83 |
|
81003
Automated urinalysis test
|
24 | 19 | $10.00 | $2.20 |
|
99496
Transitional care management services for problem of high complexity
|
21 | 16 | $494.00 | $260.80 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
18 | 17 | $30.00 | $13.12 |
|
93880
Ultrasound of both sides of head and neck blood flow
|
12 | 12 | $369.00 | $178.62 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
11 | 11 | $199.00 | $102.39 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Alprazolam | Alprazolam | 561 | 16,815 | $3,556.15 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 429 | 12,615 | $9,339.61 | 58 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 364 | 26,946 | $3,579.43 | 94 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 347 | 10,280 | $11,220.52 | 42 |
| Levothyroxine Sodium | Levothyroxine Sodium | 321 | 23,834 | $2,967.13 | 79 |
| Omeprazole | Omeprazole | 305 | 21,515 | $2,984.33 | 74 |
| Oxycodone Hcl | Oxycodone Hcl | 299 | 8,807 | $6,845.10 | 35 |
| Gabapentin | Gabapentin | 257 | 14,406 | $3,294.94 | 62 |
| Lisinopril | Lisinopril | 244 | 17,861 | $1,018.36 | 65 |
| Carvedilol | Carvedilol | 244 | 16,659 | $2,008.65 | 61 |
| Atorvastatin Calcium | Atorvastatin Calcium | 216 | 15,789 | $1,980.25 | 57 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 198 | 8,606 | $1,146.49 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 178 | 11,950 | $1,986.04 | 44 |
| Hydralazine Hcl | Hydralazine Hcl | 176 | 11,818 | $1,992.34 | 43 |
| Zolpidem Tartrate | Zolpidem Tartrate | 174 | 5,389 | $1,111.57 | 22 |
| Clonazepam | Clonazepam | 169 | 5,242 | $893.02 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 163 | 7,453 | $7,546.17 | 60 |
| Pregabalin | Pregabalin | 147 | 4,515 | $1,329.29 | 22 |
| Temazepam | Temazepam | 137 | 4,085 | $674.78 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 133 | 10,836 | $3,031.09 | 35 |
| Losartan Potassium | Losartan Potassium | 128 | 10,606 | $1,716.54 | 37 |
| Celecoxib | Celecoxib | 125 | 6,943 | $2,345.01 | 32 |
| Jardiance | Empagliflozin | 124 | 6,310 | $122,180.81 | 29 |
| Ozempic | Semaglutide | 123 | 4,034 | $120,097.35 | 24 |
| Metformin Hcl | Metformin Hcl | 122 | 8,627 | $519.02 | 31 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-02-03NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20120402000657
FL
4284695669
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Family Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 990 PALM ST STE 1, COCOA, FL 329275100 (Tel: 3216394243)
Registered at PO BOX 878, DAVENPORT, FL 338360878 (Tel: 6892233898)
NPI status registered as active in NPPES database
Registered at 990 PALM ST, COCOA, FL 329275145 (Tel: 3216394243)
Registered at PO BOX 549, SHARPES, FL 329590549 (Tel: 3216394243)
Recorded as FAIAZ RASUL, M.D.
Internal Medicine (license number reported to NPPES: FL ME72416)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Cocoa
- Dr. Raymond Baez, MD
- Dr. Hany Guirguis, MD
- Dr. Zackary Besner, MD
- Dr. Srinivas Dontineni, MD
- Dr. R Henriques, MD
Mailing Address
Po Box 878
Davenport, FL 338360878
Phone: 6892233898